Covered recipient · General Payments record
JESSICA L MUTH
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2023
$1,931.72
- Reported across 138 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $284.41 | 18 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $81.96 | 5 |
| Alkermes, Inc. | $35.79 | 2 |
| PFIZER INC. | $31.65 | 2 |
| ABBVIE INC. | $30.74 | 2 |
| Amgen Inc. | $30.66 | 2 |
| Lundbeck LLC | $16.38 | 1 |
| Lilly USA, LLC | $14.82 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $14.56 | 1 |
| Antares Pharma, Inc. | $14.38 | 1 |
| Supernus Pharmaceuticals, Inc. | $13.47 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $12.88 | 01/30/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006286117 | CMS |
| ABBVIE INC. | $17.86 | 03/31/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006286119 | CMS |
| Alkermes, Inc. | $17.43 | 01/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1022880973 | CMS |
| Alkermes, Inc. | $18.36 | 06/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1022880975 | CMS |
| Amgen Inc. | $17.96 | 02/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020357509 | CMS |
| Amgen Inc. | $12.70 | 07/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020752675 | CMS |
| Antares Pharma, Inc. | $14.38 | 04/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1054657023 | CMS |
| Lilly USA, LLC | $14.82 | 06/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1033029089 | CMS |
| Lundbeck LLC | $16.38 | 05/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032633545 | CMS |
| Novo Nordisk Inc | $18.45 | 01/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001311383 | CMS |
| Novo Nordisk Inc | $15.21 | 01/31/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001311371 | CMS |
| Novo Nordisk Inc | $18.65 | 03/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001311395 | CMS |
| Novo Nordisk Inc | $15.15 | 05/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001311355 | CMS |
| Novo Nordisk Inc | $14.50 | 07/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001311343 | CMS |
| PFIZER INC. | $15.29 | 03/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049554975 | CMS |
| PFIZER INC. | $16.36 | 06/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049518847 | CMS |
| Supernus Pharmaceuticals, Inc. | $13.47 | 01/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1053405025 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $14.56 | 05/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1055974339 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023
- Source files
- Dataset page · Bulk file · PY2021 , PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.